TrialJournal of the National Cancer Institute2019

Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy.

Michail Ignatiadis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.